ANTHRIVIG, created in 2010 (United States), from 22 sister brands and 4958 competing brands. The ANTHRIVIG brand is owned by Emergent Biosolutions, a company listed in New York. ANTHRIVIG belongs to the Drug Manufacturers business sector.

ANTHRIVIG is a brand of Emergent Biosolutions (EBS) Share price

Share price and profitability of the share Emergent Biosolutions (ANTHRIVIG)

Buy Emergent Biosolutions share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 2.53

Portfolio valuation
Emergent Biosolutions (ANTHRIVIG) over 5 years* USD 0.13

Stock market history Emergent Biosolutions (ANTHRIVIG)